Are observational studies 'just as effective' as randomized clinical trials?

Blood Purification

Volumn 18, Issue 4, 2000, Pages 317-322

  Greene, Tom ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CLINICAL RESEARCH; CONFERENCE PAPER; CORRELATION FUNCTION; DATA ANALYSIS; HUMAN; OBSERVATION; PRIORITY JOURNAL; SMOKING;

EID: 0033799093     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014455     Document Type: Conference Paper

References (22)

1. Hempel CG: Philosophy of Natural Science. Englewood Cliffs, Prentice-Hall, 1966.
2. Popper KR: The Logic of Scientific Discovery. London, Cambridge University Press, 1958.
3. Pocock SJ: Clinical Trials: A Practical Approach. New York, Wiley, 1983.
4. Greene T, Lau J, Levey AS: In Neilson EG, Couser WG (eds): Interpretation of Clinical Studies of Renal Disease, from Immunologic Renal Diseases, 1997, chap 40, pp 887-911.
5. Davey SG, Phillips AN: Confounding in epidemiological studies: Why 'independent' effects may not be all they seem. Br Med J 1992;305: 757-759.
6. Ellenberg JH: Selection bias in observational and experimental studies. Stat Med 1994;13: 557-567.
7. Eknoyan G, Levey AS, Beck GJ, Agodoa LY, Daugirdas JT, Kusek JW, Levin NW, Schulman G for the HEMO Study Group: The Hemodialysis (HEMO) Study: Rationale for selection of interventions. Semin Dial 1996;9:24-33.
8. HEMO Study Group (prepared by Greene T, Beck GJ, Gassman JJ, Gotch FA, Kusek JW, Levey AS, Levin NW, Schulman G, and Eknoyan G): Design and Statistical Issues in the Hemodialysis (HEMO) Study. Control Clin Trials 2000; in press.
9. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G: Modification of Diet in Renal Disease Study Group: The effects of dietary protein restriction and blood pressure control on the progression of renal disease. N Engl J Med 1994;330:877-884.
10. Meinert CL: Clinical Trials: Design, Conduct, and Analysis. Oxford, Oxford University Press, 1986.
11. Piantadosi S: Clinical Trials: A Methodologie Perspective. New York, Wiley, 1997.
12. Davis C: Generalizing from clinical trials. Control Clin Trials 1994; 15:11-14.
13. Bailed K: Generalizing the results of randomized clinical trials. Control Clin Trials 1994;15: 15-23.
14. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescription on patient morbidity: Report of the National Cooperative Dialysis Study. N Engl J Med 1981;305: 1176-1180.
15. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985;28:526-534.
16. Hakim RM, Breyer J, Ismail N, Schulman G: Effects of dose of dialysis on morbidity and mortality. Amer J Kidney Dis 1994;23:661-669.
17. Collins A, Liao M, Urnen A: Urea index (Kt/V) and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994;23:272-282.
18. Parker TF, Husni L, Huang W, Lew N, Lowrie EG: Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994;23:670-680.
19. Held PJ, Port FK, Wolfe RA, Stannard DC, Carroll CE, Daugirdas JT, Bloembergen WE, Greer JW, Hakim RM: The dose of hemodialysis and patient mortality. Kidney Int 1996;50: 550-556.
20. Wolfe RA, Ashby VB, Agodoa LYC, Jones CA, Port FK: Body size, dose of hemodialysis and mortality. Am J Kidney Dis 2000;35:80-88.
21. Gotch FA, Levin NW, Port FK, Wolfe RA, Uehlinger DE: Clinical outcome relative to the dose of dialysis is not what you think: The fallacy of the mean. Am J Kidney Dis 1997;30:1-15.
22. National Kidney Foundation-Dialysis Outcomes Quality Initiative: Clinical practice guidelines for hemodialysis adequacy. Am J Kidney Dis 1997;30(suppl):S22-S63.